Separative introduces a new source of value creation thanks to its molecule purification innovation, especially for the sample purification. Prolonged R&D times and high equipment costs are not inevitable!

The pharmaceutical industry is affected by three factors:

regulations
(pharmacopoeia, GMP)

The R&D investments required to
bring an active ingredient to market

equipment costs,
especially because of the pressure

SEPARATIVE offers a breakthrough technology, protected by five patents, to optimise:

Efficiency

The precision obtainable in the analysis of synthesised samples is limited by the cost of current technologies. The exploratory scope of molecules is therefore restricted and therapeutic innovations are inhibited. Significantly pushing back the boundaries of knowledge by multiplying the analytical capability can release all the potential for therapeutic innovations.

Time

Because the protection provided by a patent has a time limit, the market introduction time for a new active ingredient is an important issue. Molecule separation, whether for the purpose of analysis or sample purification, is one of the most common R&D operations. Reducing the time taken by an operation or the number of operations to be carried out to achieve the expected separation is a huge potential source of value creation.

Volume

The volumes processed to analyse or purify pharmaceutical products are enormous. And every operation requires the use of solvents. Solvents are expensive, harmful, and one of the main time-consuming steps in the separation operation. Consuming less solvent for a given separation considerably reduces the cost of the operation and is good for the environment!

The equipment

Pressure is the main factor in equipment costs ! The ability to perform the same operations at low pressure considerably reduces equipment costs. Because multicapillary chromatography is the most efficient separation method, it is becoming the standard.

Our ultra high-performance low-pressure columns open up immense potential for innovation in all molecule industries.

They provide three value-creation levers according to the application:

substantial reduction
in investment costs

increased
operating productivity

carrying out analyses
that were not possible until now

We work in close collaboration with experts from every sector to produce a breakthrough in molecule separation techniques.